相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Body mass index, diabetes, and the risk of Parkinson's disease
Su-Min Jeong et al.
MOVEMENT DISORDERS (2020)
Diabetes, BMI, and Parkinson's
Tom Foltynie et al.
MOVEMENT DISORDERS (2020)
Calbindin-D28K Limits Dopamine Release in Ventral but Not Dorsal Striatum by Regulating Ca2+ Availability and Dopamine Transporter Function
Katherine R. Brimblecombe et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Mechanisms and regulation of dopamine release
Changliang Liu et al.
CURRENT OPINION IN NEUROBIOLOGY (2019)
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Yvette C. Wong et al.
MOVEMENT DISORDERS (2019)
The Relevance of Insulin Action in the Dopaminergic System
Francesca Fiory et al.
FRONTIERS IN NEUROSCIENCE (2019)
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Inhibition of Nigrostriatal Dopamine Release by Striatal GABAA and GABAB Receptors
Emanuel F. Lopes et al.
JOURNAL OF NEUROSCIENCE (2019)
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease
Maria Nguyen et al.
TRENDS IN NEUROSCIENCES (2019)
Dissociation of Striatal Dopamine and Tyrosine Hydroxylase Expression from Aging-Related Motor Decline: Evidence from Calorie Restriction Intervention
Michael F. Salvatore et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
Ivan Martinez-Valbuena et al.
ACTA NEUROPATHOLOGICA (2018)
Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites
Changliang Liu et al.
CELL (2018)
Determinants of dopaminergic neuron loss in Parkinson's disease
Dalton James Surmeier
FEBS JOURNAL (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway
Justine Renaud et al.
NEUROBIOLOGY OF AGING (2018)
Diabetes and Parkinson disease A sweet spot?
Rohit R. Das et al.
NEUROLOGY (2018)
Diabetes mellitus and Parkinson disease
Gennaro Pagano et al.
NEUROLOGY (2018)
Association between diabetes and subsequent Parkinson disease A record-linkage cohort study
Eduardo De Pablo-Fernandez et al.
NEUROLOGY (2018)
A High-fat, High-sugar 'Western' Diet Alters Dorsal Striatal Glutamate, Opioid, and Dopamine Transmission in Mice
Brandon M. Fritz et al.
NEUROSCIENCE (2018)
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jessika C. Bridi et al.
FRONTIERS IN NEUROSCIENCE (2018)
Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
Biplab Giri et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Diabetes Mellitus to Neurodegenerative Disorders: Is Oxidative Stress Fueling the Flame?
Nandkishor K. Mule et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2018)
Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease
Kelly M. Lohr et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes
Aya Umeno et al.
FREE RADICAL RESEARCH (2017)
Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain
Kymry T. Jones et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Yu-Wan Yang et al.
MEDICINE (2017)
Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice
Oscar Solis et al.
NEUROBIOLOGY OF DISEASE (2017)
Increase in the Incidence of Diabetes and Its Implications
Julie R. Ingelfinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Embryonic defence mechanisms against glucose-dependent oxidative stress require enhanced expression of Alx3 to prevent malformations during diabetic pregnancy
Patricia Garcia-Sanz et al.
SCIENTIFIC REPORTS (2017)
Validation of optimal reference genes for quantitative real time PCR in muscle and adipose tissue for obesity and diabetes research
Lester J. Perez et al.
SCIENTIFIC REPORTS (2017)
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease
Jieyu Zhang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Mitochondrial control of cell bioenergetics in Parkinson's disease
Raquel Requejo-Aguilar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease
Johanna Duda et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease
Mariela V. Escande et al.
JOURNAL OF NEUROSCIENCE (2016)
Glycation in Parkinson's Disease and Alzheimer's Disease
Hugo Vicente Miranda et al.
MOVEMENT DISORDERS (2016)
Synaptic failure and α-synuclein
Laura Calo et al.
MOVEMENT DISORDERS (2016)
Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum
Daniela B. Pereira et al.
NATURE NEUROSCIENCE (2016)
Insulin resistance and Parkinson's disease: A new target for disease modification?
D. Athauda et al.
PROGRESS IN NEUROBIOLOGY (2016)
Retrograde Axonal Degeneration in Parkinson Disease
Patricia Tagliaferro et al.
JOURNAL OF PARKINSONS DISEASE (2016)
Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice
Irene Ruiz-DeDiego et al.
BIOLOGICAL PSYCHIATRY (2015)
Insulin enhances striatal dopamine release by activating cholinergic interneurons and thereby signals reward
Melissa A. Stouffer et al.
NATURE COMMUNICATIONS (2015)
Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
Ling Wang et al.
EXPERIMENTAL NEUROLOGY (2014)
Diet-induced obesity accelerates the onset of terminal phenotypes in α-synuclein transgenic mice
Carola Rotermund et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Protective and toxic roles of dopamine in Parkinson's disease
Juan Segura-Aguilar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
Laura Dunn et al.
NEUROBIOLOGY OF AGING (2014)
System-based approaches to decode the molecular links in Parkinson's disease and diabetes
Jose A. Santiago et al.
NEUROBIOLOGY OF DISEASE (2014)
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lin Lu et al.
PLOS ONE (2014)
Defining Midbrain Dopaminergic Neuron Diversity by Single-Cell Gene Expression Profiling
Jean-Francois Poulin et al.
CELL REPORTS (2014)
Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Bingxuan Wang et al.
CURRENT DIABETES REVIEWS (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Monoamine transporters Structure, regulation, and clinical implications
Eduardo E. Benarroch
NEUROLOGY (2013)
Diabetes is associated with postural instability and gait difficulty in Parkinson disease
Vikas Kotagal et al.
PARKINSONISM & RELATED DISORDERS (2013)
Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
Jose A. Santiago et al.
PLOS ONE (2013)
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
Stephanie Janezic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The use of animal models in diabetes research
Aileen J. F. King
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Risk of Parkinson Disease Onset in Patients With Diabetes A 9-year population-based cohort study with age and sex stratifications
Yu Sun et al.
DIABETES CARE (2012)
Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors
Andrea Anzalone et al.
JOURNAL OF NEUROSCIENCE (2012)
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Domenico Bosco et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Metabolic markers or conditions preceding Parkinson's disease: A case-control study
Rodolfo Savica et al.
MOVEMENT DISORDERS (2012)
Living on the edge with too many mouths to feed: Why dopamine neurons die
J. Paul Bolam et al.
MOVEMENT DISORDERS (2012)
L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: Insights into regulation and function
Isabel Espadas et al.
NEUROBIOLOGY OF DISEASE (2012)
Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine
S. Ares-Santos et al.
NEUROBIOLOGY OF DISEASE (2012)
Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons
Sarah Threlfell et al.
NEURON (2012)
Dopamine Transporter Loss in 6-OHDA Parkinson's Model Is Unmet by Parallel Reduction in Dopamine Uptake
Tanya Chotibut et al.
PLOS ONE (2012)
Forkhead Homeobox Type O Transcription Factors in the Responses to Oxidative Stress
Peter Storz
ANTIOXIDANTS & REDOX SIGNALING (2011)
Diabetes and Risk of Parkinson's Disease A systematic review and meta-analysis
Emanuele Cereda et al.
DIABETES CARE (2011)
Diabetes and Risk of Parkinson's Disease
Qun Xu et al.
DIABETES CARE (2011)
Insulin resistance impairs nigrostriatal dopamine function
J. K. Morris et al.
EXPERIMENTAL NEUROLOGY (2011)
Projected Numbers of People With Movement Disorders in the Years 2030 and 2050
Jan-Philipp Bach et al.
MOVEMENT DISORDERS (2011)
Obesity, Diabetes, and Risk of Parkinson's Disease
Natalia Palacios et al.
MOVEMENT DISORDERS (2011)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
Synapsins Differentially Control Dopamine and Serotonin Release
Brian M. Kile et al.
JOURNAL OF NEUROSCIENCE (2010)
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
Truyen Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver et al.
DIABETES CARE (2008)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Altered vesicular dopamine storage in Parkinson's disease: a premature demise
W. Michael Caudle et al.
TRENDS IN NEUROSCIENCES (2008)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration
Jun Peng et al.
JOURNAL OF NEUROSCIENCE (2006)
Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool
BJ Venton et al.
JOURNAL OF NEUROSCIENCE (2006)
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
N Pavon et al.
BIOLOGICAL PSYCHIATRY (2006)
Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation
LA Johnson et al.
NEUROPHARMACOLOGY (2005)
Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity
JY Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
E Bezard et al.
JOURNAL OF NEUROSCIENCE (2001)
分享论文
